Getting Great Science to Market

IT Enhances Care, Research, and Operations

August 1, 2014

In keeping with Partners HealthCare rich history of discovery, clinicians and technologists are setting the pace for innovation in health care IT. Technological feats ranging from virtual visits to personalized medicine are redefining modern health care and inspiring a slew of questions about the limits—and seemingly endless possibilities—of information technology. The rapidly expanding digital health…

Read More

Targeting Nanotechnology: BIND Therapeutics

August 1, 2014

A look into the targeted nanoparticle therapies known as Accurins—developed by BIND Therapeutics, the brainchild of Partners HealthCare innovator Omid Farokhzad, MD, and MIT legend Robert Langer, ScD. Cancer cells may give traditional chemotherapies short shrift, but the targeted nanoparticle therapies known as Accurins—developed by BIND Therapeutics, the brainchild of Partners HealthCare innovator Omid Farokhzad,…

Read More

Putting Innovation to Work – Surgery at Partners HealthCare

May 1, 2014

A behind the scenes look at surgical innovations across Partners HealthCare. From image-guided operating rooms to whole organ regeneration, the departments of surgery at the Massachusetts General Hospital (MGH) and Brigham and Women's Hospital (BWH) are blazing new trails in surgical innovation. “The stereotypical surgeon is in the operating room, focusing on the best of…

Read More

Innovation is Standard at McLean

May 1, 2014

The unique history of innovation that sets McLean Hospital apart from most freestanding psychiatric hospitals. Freestanding psychiatric hospitals sometimes find their reputations entwined in a history of tried-and-true traditional intervention, with cutting-edge research taking a backseat. But at McLean Hospital a history of innovation sets the institution apart. “McLean is one of the first institutions…

Read More

Technology Profile: New Point-of-Care Diagnostic for Epilepsy

December 1, 2013

Utkan Demirci, PhD collaborated with neurologist Steven Schachter, MD, to design a disposable microfluidic chip that can immediately detect the levels of antiepileptic drugs based on a finger-prick sample of blood. People suffering from epilepsy have long been at a disadvantage when trying to optimize the effectiveness of their antiepileptic drugs (AEDs). To do so…

Read More